Back | Next |
home / stock / abbv / abbv message board
News, Short Squeeze, Breakout and More Instantly...
Cantor Fitzgerald has initiated coverage on AbbVie Inc (NYSE:ABBV), a global pharma company. The analyst notes that the company has ...
AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease Week® PR Newswire - AbbVie will present 15 abstracts, including three oral presentations, in Crohn's disease and ulcerative colitis reinforcing AbbVie's commitment to advancin...
AbbVie (NYSE:ABBV) has outperformed the market over the past 5 years by 1.96% on an annualized basis producing an average annual return of 15.08%. ...